SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about trading window closure

27 Mar 2024 Evaluate
Emmessar Biotech & Nutrition has informed that pursuant to Clause 4 of the Schedule B of Prohibition of Insider Trading Regulations, as amended, of the SEBI [PIT] Regulations, 2015, as amended, The Trading Window for dealing in the securities of the Company, will remain closed with effect from April 01, 2024 till May 31, 2024 for considering the financial results for the quarter / year ending March 31, 2024. Accordingly, all insiders/ designated persons and their relatives are advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

27.40 1.11 (4.22%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×